Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 7/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.35 |
| ▸ | MET | P08581 | 3/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.34 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14104442 | 0.93 | MET (0.38) | L3MBTL1TRPA1MAPK1MAPTABCG2 | |
| SCHEMBL14104446 | 0.93 | TRPA1 (0.41) | L3MBTL1TRPA1MAPK1MAPTABCG2 | |
| SCHEMBL14103756 | 0.90 | TRPA1 (0.41) | L3MBTL1TRPA1MAPK1MAPTMET | |
| SCHEMBL14103816 | 0.89 | MTOR (0.40) | L3MBTL1TRPA1MAPK1MAPTMET | |
| SCHEMBL14103813 | 0.89 | PIK3CA (0.40) | L3MBTL1TRPA1MAPK1MAPTMET | |
| SCHEMBL14103885 | 0.89 | TRPA1 (0.38) | L3MBTL1TRPA1MAPK1MAPTMET | |
| SCHEMBL14103795 | 0.88 | L3MBTL1 (0.39) | L3MBTL1TRPA1MAPK1MAPTABCG2 | |
| SCHEMBL14103797 | 0.88 | HTT (0.47) | L3MBTL1TRPA1MAPK1MAPTABCG2 | |
| SCHEMBL4574977 | 0.87 | MAPK1 (0.51) | L3MBTL1TRPA1MAPK1MAPTMET | |
| SCHEMBL14103771 | 0.86 | TRPA1 (0.37) | L3MBTL1TRPA1MAPK1MAPTMET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008092861-A1 | BICYCLIC DERIVATIVES AS EP4 AGONISTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-08-07 | — | — | WO | disclosed |